HDAC6 and androgen insensitivity syndrome: It is notable that our systematic literature search identified only seven articles investigating the potential for HDAC6 inhibition to improve AIS outcomes and only one identified study was suggested to have a low risk of overall bias.44 Importantly, meta-analysis assessing the influence of HDAC6 inhibition on cerebral infarction volume did not suggest any publication bias.